Rui Wei
Impact in
-
- Nanoplatforms for cancer theranostics
- Thermochemical Biomass Conversion Processes
- Biofuel production and bioconversion
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 3
-
- Nanoplatforms for cancer theranostics 7
- Co-authors
- Guiying Jiang (14 shared papers)Fei Li (11 shared papers)Ding Ma (9 shared papers)Ying Zhou (11 shared papers)Jili Zhang (1 shared paper)Yan Huang (1 shared paper)Sylvia H. Larsson (1 shared paper)Ling Liu (1 shared paper)
- Journals
- Journal of Nanobiotechnology (2 papers)European Journal of Medicinal Chemistry (1 paper)Oncology Reports (1 paper)Nanomedicine (1 paper)Cancer Biology and Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Rui Wei
18 papers receiving 396 citations
Peers
Comparison fields: 5 of 89
- Biomedical Engineering 200
- Biomaterials 51
- Oncology 90
- Cancer Research 42
- Immunology 48
Countries citing papers authored by Rui Wei
This map shows the geographic impact of Rui Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Wei more than expected).
Fields of papers citing papers by Rui Wei
This network shows the impact of papers produced by Rui Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Wei. The network helps show where Rui Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Rui Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 83 | |
| 2 | 2019 | 42 | |
| 3 | 2017 | 36 | |
| 4 | 2014 | 34 | |
| 5 | 2021 | 23 | |
| 6 | 2019 | 22 | |
| 7 | 2018 | 21 | |
| 8 | 2021 | 21 | |
| 9 | 2019 | 21 | |
| 10 | 2023 | 19 | |
| 11 | 2019 | 18 | |
| 12 | 2017 | 15 | |
| 13 | 2019 | 14 | |
| 14 | 2024 | 10 | |
| 15 | 2015 | 8 | |
| 16 | 2022 | 6 | |
| 17 | 2023 | 4 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Rui Wei
Rui Wei is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Immunology and Psychiatry and Mental health, having authored 21 papers that have together received 398 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Cancer Cells and Metastasis (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), RNA Interference and Gene Delivery (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Biomedical Engineering (200 citations), Biomaterials (51 citations), Oncology (90 citations), Cancer Research (42 citations) and Immunology (48 citations). Rui Wei has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Guiying Jiang, Fei Li, Ding Ma, Ying Zhou, Jili Zhang, Yan Huang, Sylvia H. Larsson, Ling Liu, Michael Finell and Danfeng Luo. Their work appears in journals such as Journal of Nanobiotechnology, European Journal of Medicinal Chemistry, Oncology Reports, Nanomedicine and Cancer Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.